User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

Search results

  1. Subclinical hypothyroidism and coronary heart disease: A case for early detection and treatment

    ... [95% CI, 1.43 to 4.74]), despite being thyroid peroxidase antibody (TPO) negative. Those with SCH and positive anti-TPO antibody had an even higher risk of CHD mortality (HR: 1.8 [95% CI, 1.07 to ...

  2. Congress Report: 16th Latin American Thyroid Society (LATS)

    ... active ophthalmopathy, including teprotumumab, a monoclonal antibody that inhibits the insulin-like growth factor I receptor (IGF-IR), ... women. Levothyroxine therapy is recommended for: TPO antibody positive women with a TSH greater than the pregnancy-specific ...

  3. Aggressive “case finding” is warranted for subclinical hypothyroidism

    ... TSH was between 2.5–10 mU/L, thyroid peroxidase antibody (TPOAb) levels were assessed, and were found to be elevated, ... Since levothyroxine therapy is recommended for TPO antibody positive women with a TSH greater than the pregnancy-specific ...

  4. Congress Report: ENDO 2016

    ... present, thyroid peroxidase (TPO) and anti- TSH receptor antibody tests may be positive and ultrasonography may show increased ... is reasonable.  Measuring the maternal thyroid receptor antibody levels is recommended in early pregnancy for women with a history of ...

  5. Recommended reading

    ... D, Rodondi N; Thyroid Studies Collaboration. Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart ...

  6. Recommended reading – key published papers from 2017 as chosen by our Scientific Committee Members

    ... the excellent efficacy of a novel IgF1 receptor monoclonal antibody in the treatment of patients with active and severe thyroid eye ...

  7. Highlights from the European Thyroid Association Annual Meeting, September 15-18, 2018, Newcastle-upon-Tyne, UK

    ... sclerosis who had received lymphocyte-depleting alemtuzumab antibody treatment. Of these, 20–30% developed TSH -R-antibody positive Graves’ disease . A similar pattern of AITD has been ...

  8. Highlights of the 39th European Thyroid Association Annual Meeting

    ... ETA pregnancy thyroid-stimulating hormone receptor antibody bioassays Graves’ orbitopathy Specialty area(s) ...

  9. Scientific Highlights: Diabetes and thyroid diseases: clinical features and management

    ... (4.5–10 mIU/l) in the absence of other conditions such as antibody positivity; in such patients, TSH levels should be monitored every ...

  10. Scientific Highlights from the 2015 International Thyroid Association Congress

    ... reflecting that treatment of thyroid peroxidase antibody positive pregnant women with LT4 might reduce miscarriage. Castillo ...

Pages